Neoadjuvant relatlimab and nivolumab in resectable melanoma (vol 611, pg 155, 2022)

被引：1
|
作者：
Amaria, Rodabe N.
Postow, Michael
Burton, Elizabeth M.
Tetzlaff, Michael T.
Ross, Merrick I.
Torres-Cabala, Carlos
Glitza, Isabella C.
Duan, Fei
Milton, Denai R.
Busam, Klaus
Simpson, Lauren
McQuade, Jennifer L.
Wong, Michael K.
Gershenwald, Jeffrey E.
Lee, Jeffrey E.
Goepfert, Ryan P.
Keung, Emily Z.
Fisher, Sarah B.
Betof-Warner, Allison
Shoushtari, Alexander N.
Callahan, Margaret
Coit, Daniel
Bartlett, Edmund K.
Bello, Danielle
Momtaz, Parisa
Nicholas, Courtney
Gu, Aidi
Zhang, Xuejun
Korivi, Brinda Rao
Patnana, Madhavi
Patel, Sapna P.
Diab, Adi
Lucci, Anthony
Prieto, Victor G.
Davies, Michael A.
Allison, James P.
Sharma, Padmanee
Wargo, Jennifer A.
Ariyan, Charlotte
Tawbi, Hussein A.
机构：
来源：
NATURE | 2023年 / 615卷 / 7953期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1038/s41586-023-05892-1
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：E23 / E23
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma (vol 24, pg 1649, 2018)
    Amaria, Rodabe N.
    Reddy, Sangeetha M.
    Tawbi, Hussein A.
    Davies, Michael A.
    Ross, Merrick I.
    Glitza, Isabella C.
    Cormier, Janice N.
    Lewis, Carol
    Hwu, Wen-Jen
    Hanna, Ehab
    Diab, Adi
    Wong, Michael K.
    Royal, Richard
    Gross, Neil
    Weber, Randal
    Lai, Stephen Y.
    Ehlers, Richard
    Blando, Jorge
    Milton, Denai R.
    Woodman, Scott
    Kageyama, Robin
    Wells, Daniel K.
    Hwu, Patrick
    Patel, Sapna P.
    Lucci, Anthony
    Hessel, Amy
    Lee, Jeffrey E.
    Gershenwald, Jeffrey
    Simpson, Lauren
    Burton, Elizabeth M.
    Posada, Liberty
    Haydu, Lauren
    Wang, Linghua
    Zhang, Shaojun
    Lazar, Alexander J.
    Hudgens, Courtney W.
    Gopalakrishnan, Vancheswaran
    Reuben, Alexandre
    Andrews, Miles C.
    Spencer, Christine N.
    Prieto, Victor
    Sharma, Padmanee
    Allison, James
    Tetzlaff, Michael T.
    Wargo, Jennifer A.
    NATURE MEDICINE, 2018, 24 (12) : 1942 - 1942
  • [22] Neoadjuvant nivolumab versus combination ipilimumab and nivolumab followed by adjuvant nivolumab in patients with resectable stage III and oligometastatic stage IV melanoma: preliminary findings
    Reddy, Sangeetha M.
    Amaria, Rodabe N.
    Spencer, Christine N.
    Tetzlaff, Michael
    Reuben, Alexandre
    Andrews, Miles
    Wang, Linghua
    Woodman, Scott
    Zhu, Haifeng
    Blando, Jorge
    Vence, Luis
    Zhang, Shaojun
    Jiang, Hong
    Gopalakrishnan, Vancheswaran
    Hudgens, Courtney
    Wani, Khalida
    Tawbi, Hussein
    Diab, Adi
    Glitza, Isabella
    Patel, Sapna
    Hwu, Wen-Jen
    Wong, Michael
    Hwu, Patrick
    Cormier, Janice
    Lucci, Anthony
    Royal, Richard
    Lee, Jeffrey E.
    Simpson, Lauren
    Burton, Elizabeth M.
    Gershenwald, Jeffrey E.
    Ross, Merrick
    Allison, James
    Sharma, Padmanee
    Davies, Michael
    Wargo, Jennifer
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [23] Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.
    Lucas, Minke W.
    Scolyer, Richard A.
    van de Wiel, Bart A.
    Menzies, Alexander M.
    Lopez-Yurda, Marta I.
    van Akkooi, Alexander Christopher Jonathan
    van Houdt, Winan J.
    Saw, Robyn P. M.
    Torres Acosta, Alex
    Lo, Serigne N.
    Hospers, Geke
    Carlino, Matteo S.
    de Groot, Jan Willem
    Kapiteijn, Ellen
    Suijkerbuijk, Karijn
    Rutkowski, Piotr
    Sandhu, Shahneen
    van der Veldt, Astrid Aplonia Maria
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL)
  • [24] Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma (vol 30, pg 6953, 2023)
    Holder, Ashley M.
    Wargo, Jennifer A.
    Ross, Merrick I.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (12) : 7688 - 7688
  • [25] Be modest: you're living on the edge (vol 81, pg 611, 2022)
    Dorst, Kevin
    ANALYSIS, 2022, 82 (03) : 473 - 473
  • [26] Nivolumab and Ipilimumab in Advanced Melanoma (vol 377, pg 2503, 2017)
    Eggermont, A. M. M.
    Chiarion-Sileni, V.
    Grob, J. -J.
    Dummer, R.
    Wolchok, J. D.
    Schmidt, H.
    Hamid, O.
    Robert, C.
    Ascierto, P. A.
    Richards, J. M.
    Lebbe, C.
    Ferraresi, V.
    Smylie, M.
    Weber, J. S.
    Maio, M.
    Bastholt, L.
    Mortier, L.
    Thomas, L.
    Tahir, S.
    Hauschild, A.
    Hassel, J. C.
    Hodi, F. S.
    Taitt, C.
    de Pril, V.
    de Schaetzen, G.
    Suciu, S.
    Testori, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2185 - 2185
  • [27] Distant metastasis-free survival of neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in resectable, macroscopic stage III melanoma: The NADINA trial
    Lucas, M. W.
    Menzies, A. M.
    Lopez-Yurda, M.
    Scolyer, R. A.
    van de Wiel, B.
    Saw, R. P. M.
    Van Houdt, W.
    Maher, N.
    Acosta, A. Torres
    Boers-Sonderen, M.
    Hospers, G.
    Carlino, M. S.
    de Groot, J. W.
    Kapiteijn, E.
    Suijkerbuijk, K.
    Rutkowski, P.
    Sandhu, S. K.
    Van der Veldt, A. A. M.
    Long, G. V.
    Blank, C. U.
    ANNALS OF ONCOLOGY, 2024, 35 : 1233 - 1234
  • [28] Neoadjuvant nivolumab or nivolumab plus relatlimab in patients with resectable non-small cell lung cancer: a randomized, multicentric phase II study to define feasibility, efficacy and biomarkers of response (NEOpredict-Lung)
    Schuler, M.
    Baas, P.
    Cuppens, K.
    Ploenes, T.
    Wiesweg, M.
    Paschen, A.
    Hegedues, B.
    Reis, H.
    Mairinger, F.
    Kvistborg, P.
    Schramm, A.
    Aigner, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 154 - 154
  • [29] Nivolumab plus Ipilimumab in Advanced Melanoma (vol 369, pg 122, 2013)
    Ribas, Antoni
    Hodi, F. Stephen
    Callahan, Margaret
    Konto, Cyril
    Wolchok, Jedd
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2185 - 2185
  • [30] Status of Neoadjuvant Therapy for Resectable Pancreatic Cancer (vol 19, pg 411, 2010)
    Hoffman, John P.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (03) : XVII - XVII
12345